Two glucosyltransferase isozymes from Phytolacca americana, PaGT3 and PaGT2, catalyzed stereo-and regio-selective monoglucosylation of 3,5,3′,4′tetrahydroxy-trans-stilbene to yield 3,5,3′,4′-tetrahydroxy-trans-stilbene-4′-O--D-glucopyranoside.
Plant cells contain a range of enzymes that produce secondary metabolites for either self-defense or signal transduction [1] . To utilize these intrinsic abilities, we have studied biotransformation of exogenous compounds in cultured plant cells [2] . The method is applicable to endowing organic compounds with more useful properties by hydrolysis, oxidation, reduction, esterification, isomerization, and glycosylation [3a,b] . Glycosylation is especially an important chemical modification because glycosylated bioactive compounds exhibit better water solubility and physiochemical stability [4a] . In this study, we report highly stereo-and regioselective glucosylation of 3,5,3′,4′-tetrahydroxy-trans-stilbene (piceatannol) by two glucosyltransferase isozymes from Phytolacca americana, PaGT3 and PaGT2 (Figure 1 ) [2] .
In nature, hydroxylated trans-stilbene and its glycosides are present in Chinese herbal medicine. For example, piceatannol and piceatannol-3,4'-O-diglucopyranoside were isolated from Rheum undulatum
[4b].
Piceatannol-4'-O-glucopyranoside and piceatannol-3-O-glucopyranoside were identified in Polygonum cuspidatum and Eskemukerjea megacarpum, respectively [5a,b] . The limited supply of piceatannol and its glycosides from nature motivated organic chemists to develop several synthetic procedures. Jun et al. reported a six steps reaction procedure to synthesize piceatannol from vanillin using Sonogashira coupling reaction [5c]. On the other hand, the syntheses of piceatannol glycosides have not been studied intensively. The enzymatic conversion by glucosyltransferase described here may be useful to produce the glucosides of hydroxyl trans-stilbene.
When piceatannol was incubated with uridine diphosphate (UDP)glucose in the presence of purified PaGT3, two glucoside products were obtained. Under reverse-phase HPLC conditions, the products eluted faster than piceatannol. Approximately 90% of piceatannol was converted into glucosides, and the major product eluted at a retention time of 12 min. The reaction was fairly selective with a major/minor product ratio of 95:5. The electrospray mass spectra of these products showed a molecular ion [M+H] + peak at m/z 407, suggesting a molecular formula of C 20 H 22 O 9 (calculated for 406). We also observed the adduct ion peaks at m/z 429 for [M+Na] + and at m/z 445 for [M+K] + . These results indicated that piceatannol was monoglucosylated by PaGT3.
To determine the stereo-and regio-selectivity, we performed NMR analysis of the major glucoside product. The -configuration was confirmed by an anomeric proton signal at  4.78 (1H, d, J = 7.6 Hz) in the 1 H NMR spectrum. A comparison of the 13 C NMR chemical shifts of piceatannol and its glucoside allowed us to determine the glucosylated site (Table 1 ). Upon glucosylation of piceatannol, the C-4′ signal shifted from 145.1 ppm to 146.5 ppm. In contrast, we observed an upfield shift of 13 C signals corresponding to C-3′ and C-5′, adjacent to the glucosylation site (i.e., C-4′). These spectral data were consistent with the previous report on the glucoside of piceatannol, suggesting that the major glucoside produced by PaGT3 was 3,5,3′,4′-tetrahydroxy-transstilbene-4′-O--D-glucopyranoside [5a] . We previously reported that PaGT3 catalyzes regioselective glucosylation of 3,5,4′trihydroxy-trans-stilbene (resveratrol) with a ratio of 4′-O--Dglucopyranoside: 3-O--D-glucopyranoside of 77:23 [6] . The hydroxyl group at C3′ in piceatannol appeared to promote the addition of a glucose moiety at the C4′ carbon.
Next, we examined whether we could use E. coli cells to transform piceatannol into its glucosides. When PaGT3-expressing E. coli cells were cultured in the presence of piceatannol, the monoglucosylated products accumulated in the overnight culture medium. In this system, the addition of relatively expensive UDP-glucose was not required because E. coli cells could generate glucosyl donor molecules endogenously. Furthermore, the glucosylation proceeded almost quantitatively and the products could be easily isolated from the medium by adsorption on Diaion HP20 resin. It was previously reported that cell suspension cultures of Vitis vinifera, particularly after elicitation, were able to biosynthesize over 20 different stilbenoids [7, 8] . However, the glucosides were present in low concentration in the extract. The biotransformation by GT-expressing E. coli cells described here might be applicable to the mass production of various glucosides.
Finally, we examined whether piceatannol was also a substrate for PaGT2, an isozyme from P. americana. The incubation of piceatannol and UDP-glucose in the presence of purified PaGT2 enzyme produced exclusively 4′-O--D-glucopyranoside in almost 100% yield. Interestingly, resveratrol was not a substrate for PaGT2. In the incubation with PaGT2, the replacement of the OH group at C-3′ with a hydrogen atom deprived piceatannol of the ability to accept a glucose moiety. Although the crystal structures of PaGTs have not been determined, the elucidation of active site structures may provide important insights into the substrate specificities of these enzymes.
In summary, purified PaGT3 and PaGT2 catalyzed the monoglucosylation of piceatannol to yield its 4′-O--D-glucopyranoside. We also found that PaGT-expressing E. coli cells could be utilized for this biotransformation. PaGTs show promise as biocatalysts for synthesizing glucosylated prodrugs, prosupplements, and procosmetics.
Experimental
General: All chemicals were purchased from Wako, Nakalai, and Sigma-Aldrich. MS, JEOL, MS station JMS-700 spectrometer; NMR, Varian XL-400 spectrometer. LC analysis was performed on either a Shimadzu or Hitachi HPLC system.
Expression and purification of PaGT:
Expression and purification of PaGT3 and 2 were performed as described previously [2, 6] . PaGT3 and 2 cDNA were cloned into pQE30, and the resulting plasmids were transformed into E. coli M15 cells. The transformants were grown in the LB medium with continuous shaking at 30°C. The harvested cells were resuspended in buffer A (15 mM potassium phosphate, 1 mM EDTA, 2 mM 2mercaptoethanol). Cells were lysed by sonication, and cellular debris was removed by centrifugation. The supernatant was applied to a His-accept column equilibrated with buffer A. The column was washed with buffer A to remove impurities, and the bound PaGT enzyme was eluted with buffer A supplemented with 200 mM imidazole. The purified enzyme solution was dialyzed with 50 mM Tris-HCl (pH 7.2) containing 100 mM NaCl and 5 mM dithiothreitol, and stored at -80°C.
Glucosylation of piceatannol:
Glucosylation reactions were performed at 37°C for 60 min in 0.5 mL of 50 mM potassium phosphate buffer (pH 7.2) supplemented with 50 M piceatannol, 100 M UDP-glucose, and 5 M enzyme. The incubation was stopped by adding 1.5% trifluoroacetic acid; the reaction mixture was analyzed by HPLC. For glucosylation of piceatannol in E. coli cultures, M15 cells bearing pQE-PaGT were cultured in 10 mL LB medium containing 1 mg piceatannol and 0.5 mg ampicillin. At 16 h after induction with 0.1 mM IPTG, the cells and medium were separated. The medium was applied to Diaion HP20 (1 g), washed with water, and eluted with methanol. The methanol solution was analyzed by HPLC. For a large-scale experiment, the incubation was performed in 500 mL LB containing 50 mg of piceatannol.
HPLC analysis:
The substrates and glucosylated products were separated using Inertsil ODS-3 (4.6 × 250 mm). The ratio of water and acetonitrile was 85:15 (v/v) at t = 0 min and increased to 80:20 (v/v) at t = 15 min. The flow rate was 1 mL/min, and the UV-visible detector was set at 320 nm.
